Home / NEWS / Business / Johnson & Johnson shares slip after jury orders it to pay $29 million in latest talcum cancer trial

Johnson & Johnson shares slip after jury orders it to pay $29 million in latest talcum cancer trial

Johnson & Johnson divide ups were down Thursday after the company was ordered by a California jury to pay $29 million to a woman who alleged that asbestos in the house’s talcum-powder-based products caused her cancer.

It was the latest defeat for J&J, which is facing thousands of similar lawsuits. The company gainsays allegations that its talc causes cancer, saying numerous studies and tests by regulators worldwide have postured that its talc is safe and asbestos-free.

The New Jersey-based company said it will appeal the verdict, which was made in California Nonpareil Court in Oakland.

“We respect the legal process and reiterate that jury verdicts are not medical, scientific or regulatory conclusions prevalent a product,” J&J said in a statement. “We are disappointed with [Wednesday’s] verdict and will pursue an appeal because Johnson’s Babe Powder does not contain asbestos or cause cancer.”

J&J faces more than 13,000 talc-related lawsuits. A Los Angeles jury final year awarded $21.7 million to a woman who blamed her cancer on the powder. J&J also lost a motion to reverse a jury verdict in Missouri that accorded more than $4 billion to 22 women who blamed their ovarian cancer on asbestos in the company’s products.

J&J relaunched its iconic namesake neonate product line last summer to reverse a decline in J&J’s baby care unit. While trusted for decades, the 124-year-old trade name had fallen out of touch with consumers, namely millennial moms, who opted instead for cleaner, natural products from now upstart brands.

J&J, which has a market cap of $371.3 billion, has seen its shares climb more than 8 percent since the source of this year. The stock is up nearly 4 percent over the past 12 months.

— CNBC’s Angelica LaVito and Reuters have a hand ined to this report.

Check Also

Cramer Remix: Levi’s stock is too rich to buy after its high-flying IPO

Levi Strauss & Co, the maker of Levi’s jeans, kicked off the IPO excitement by …

Leave a Reply

Your email address will not be published. Required fields are marked *